The years of research pertaining to regenerative medicine, including cellular therapies have confirmed the potential use of combination therapies including mesenchymal stem cells and exosomes to treat multiple liver ailments. There are currently around 16 clinical trials going on using mesenchymal stem cells worldwide, and all of them have confessed that MSCs would be the ideal candidates for treating liver diseases by managing both tissue damage and the overactivation of inflammation.